. "0862-8947" . . . "pemetrexed; lung cancer"@en . "I" . . "Pemetrexed"@cs . . "RIV/00064203:_____/09:8887" . . "Pemetrexed"@cs . "332998" . "Pemetrexed je antifol\u00E1tov\u00E9 cytostatikum, kter\u00E9 prok\u00E1zalo \u00FA\u010Dinnost v l\u00E9\u010Db\u011B nemalobun\u011B\u010Dn\u00E9ho karcinomu plic (NSCLC). V sou\u010Dasn\u00E9 dob\u011B se v klinick\u00E9 praxi pou\u017E\u00EDv\u00E1 ve \u010Dty\u0159ech indikac\u00EDch, tj. v prvn\u00ED linii l\u00E9\u010Dby malign\u00EDho mezoteliomu pleury a v prvn\u00ED linii, v udr\u017Eovac\u00ED terapii a ve druh\u00E9 linii l\u00E9\u010Dby nemalobun\u011B\u010Dn\u00E9ho karcinomu plic. Pemetrexed prokazuje stabiln\u011B vy\u0161\u0161\u00ED \u00FA\u010Dinnost u neskvam\u00F3zn\u00EDch typ\u016F tumoru. Posledn\u00ED v\u00FDsledky v indikaci udr\u017Eovac\u00ED terapie p\u0159inesly nov\u00FD n\u00E1hled na standardn\u00ED l\u00E9\u010Debn\u00E9 re\u017Eimy NSCLC."@cs . . "5" . "Pemetrexed je antifol\u00E1tov\u00E9 cytostatikum, kter\u00E9 prok\u00E1zalo \u00FA\u010Dinnost v l\u00E9\u010Db\u011B nemalobun\u011B\u010Dn\u00E9ho karcinomu plic (NSCLC). V sou\u010Dasn\u00E9 dob\u011B se v klinick\u00E9 praxi pou\u017E\u00EDv\u00E1 ve \u010Dty\u0159ech indikac\u00EDch, tj. v prvn\u00ED linii l\u00E9\u010Dby malign\u00EDho mezoteliomu pleury a v prvn\u00ED linii, v udr\u017Eovac\u00ED terapii a ve druh\u00E9 linii l\u00E9\u010Dby nemalobun\u011B\u010Dn\u00E9ho karcinomu plic. Pemetrexed prokazuje stabiln\u011B vy\u0161\u0161\u00ED \u00FA\u010Dinnost u neskvam\u00F3zn\u00EDch typ\u016F tumoru. Posledn\u00ED v\u00FDsledky v indikaci udr\u017Eovac\u00ED terapie p\u0159inesly nov\u00FD n\u00E1hled na standardn\u00ED l\u00E9\u010Debn\u00E9 re\u017Eimy NSCLC." . "Pemetrexed, Therapy"@en . "http://www.remedia.cz/Archiv-rocniku/Rocnik-2009/5-2009/Pemetrexed/e-a7-ac-L2.magarticle.aspx" . . "Pemetrexed" . "1"^^ . . . "5"^^ . "Remedia" . . "19" . "Pemetrexed is antifol\u00E1tov\u00E9 antineoplastic agent that has shown efficacy in the treatment of non-small cell lung cancer (NSCLC). Currently in clinical practice used in four indications, ie in the first-line treatment of malignant pleural mesothelioma in the first line, in maintenance therapy and in second-line treatment of non-small cell lung cancer. Pemetrexed demonstrated consistently higher efficacy in neskvam\u00F3zn\u00EDch tumor types. Latest results for the indication of maintenance therapy brought new insights to standard treatment regimens NSCLC."@en . . "Pemetrexed, Therapy"@en . "CZ - \u010Cesk\u00E1 republika" . "[211B8F3B1CBB]" . . "1"^^ . "Koubkov\u00E1, Leona" . "Pemetrexed" . "RIV/00064203:_____/09:8887!RIV13-MZ0-00064203" .